Squarepoint’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.19M Sell
127,824
-124,632
-49% -$2.13M ﹤0.01% 1138
2025
Q1
$16.1M Buy
252,456
+222,136
+733% +$14.2M 0.02% 421
2024
Q4
$3.69M Buy
30,320
+1,512
+5% +$184K ﹤0.01% 899
2024
Q3
$3.6M Buy
28,808
+12,386
+75% +$1.55M 0.01% 874
2024
Q2
$2.59M Buy
16,422
+12,946
+372% +$2.05M ﹤0.01% 952
2024
Q1
$450K Buy
+3,476
New +$450K ﹤0.01% 1726
2023
Q4
Sell
-32,141
Closed -$3.9M 2937
2023
Q3
$3.9M Sell
32,141
-54,670
-63% -$6.63M 0.01% 700
2023
Q2
$9.94M Sell
86,811
-13,779
-14% -$1.58M 0.03% 368
2023
Q1
$13.9M Sell
100,590
-105,906
-51% -$14.6M 0.06% 254
2022
Q4
$26.8M Buy
206,496
+64,394
+45% +$8.34M 0.11% 117
2022
Q3
$15.7M Buy
142,102
+23,527
+20% +$2.6M 0.08% 182
2022
Q2
$8.89M Buy
118,575
+15,866
+15% +$1.19M 0.05% 293
2022
Q1
$8.02M Buy
102,709
+69,880
+213% +$5.46M 0.03% 352
2021
Q4
$2.96M Buy
+32,829
New +$2.96M 0.01% 698
2021
Q2
Sell
-61,187
Closed -$4.56M 3006
2021
Q1
$4.56M Buy
61,187
+59,372
+3,271% +$4.42M 0.03% 451
2020
Q4
$309K Sell
1,815
-25,698
-93% -$4.38M ﹤0.01% 1839
2020
Q3
$3.86M Sell
27,513
-31,153
-53% -$4.38M 0.05% 407
2020
Q2
$9.41M Buy
58,666
+48,566
+481% +$7.79M 0.15% 182
2020
Q1
$988K Sell
10,100
-14,904
-60% -$1.46M 0.03% 724
2019
Q4
$3.23M Buy
+25,004
New +$3.23M 0.02% 636
2019
Q3
Sell
-14,067
Closed -$2.14M 2529
2019
Q2
$2.14M Sell
14,067
-11,915
-46% -$1.81M 0.02% 797
2019
Q1
$3.1M Buy
+25,982
New +$3.1M 0.03% 594
2018
Q3
Sell
-36,055
Closed -$4.77M 2203
2018
Q2
$4.77M Buy
36,055
+10,295
+40% +$1.36M 0.06% 417
2018
Q1
$1.91M Buy
25,760
+4,562
+22% +$338K 0.03% 594
2017
Q4
$1.18M Sell
21,198
-12,348
-37% -$687K 0.02% 748
2017
Q3
$1.52M Buy
33,546
+19,731
+143% +$895K 0.03% 567
2017
Q2
$466K Sell
13,815
-27,958
-67% -$943K 0.01% 975
2017
Q1
$1.24M Sell
41,773
-4,965
-11% -$147K 0.03% 524
2016
Q4
$1.28M Buy
+46,738
New +$1.28M 0.05% 417